Figure 2: Change of NLR at baseline (pre-treatment, n = 517), after the completion of dCRT (post-treatment, n = 517), and at tumor progression (n = 436). | Scientific Reports

Figure 2: Change of NLR at baseline (pre-treatment, n = 517), after the completion of dCRT (post-treatment, n = 517), and at tumor progression (n = 436).

From: Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

Figure 2

Horizontal lines inside the box plots represent the median, boxes represent the interquartile range, and whiskers represent 97.5th and 2.5th percentiles.

Back to article page